These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 11344175

  • 21. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
    Colao A, Di Somma C, Rota F, Pivonello R, Savanelli MC, Spiezia S, Lombardi G.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
    [Abstract] [Full Text] [Related]

  • 22. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV, Spina LD, de Lima Oliveira Brasil RR, da Silva EM, Lobo PM, Salles E, Coeli CM, Conceição FL, Vaisman M.
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [Abstract] [Full Text] [Related]

  • 23. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
    Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G.
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
    [Abstract] [Full Text] [Related]

  • 24. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G, Albertsson-Wikland K, Bengtsson BA.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [Abstract] [Full Text] [Related]

  • 25. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [Abstract] [Full Text] [Related]

  • 26. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Morte AM, Pivonello R, Nicolai E, Salvatore M, Lombardi G.
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):447-55. PubMed ID: 10762287
    [Abstract] [Full Text] [Related]

  • 29. Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
    Capalbo D, Mattace Raso G, Esposito A, Di Mase R, Barbieri F, Meli R, Bruzzese D, Salerno M.
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):856-62. PubMed ID: 24372071
    [Abstract] [Full Text] [Related]

  • 30. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P, Koltowska-Häggström M.
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [Abstract] [Full Text] [Related]

  • 31. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J, Tołwińska J, Urban M, Gardziejczyk M, Głowińska B.
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [Abstract] [Full Text] [Related]

  • 32. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [Abstract] [Full Text] [Related]

  • 33. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
    Colao A, Di Somma C, Filippella M, Rota F, Pivonello R, Orio F, Vitale G, Lombardi G.
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
    [Abstract] [Full Text] [Related]

  • 34. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A, Amato MC, Criscimanna A, Mattina A, Vetro C, Galluzzo A, D'Acquisto G, Giordano C.
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [Abstract] [Full Text] [Related]

  • 35. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C, Thilén U, Ahrén B, Erfurth EM.
    J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
    [Abstract] [Full Text] [Related]

  • 36. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J, Svensson J, Götherström G, Sunnerhagen KS, Bengtsson B, Johannsson G.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [Abstract] [Full Text] [Related]

  • 37. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B, Smethurst LE, Mukherjee A, Jostel A, Shalet SM, Murray RD.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [Abstract] [Full Text] [Related]

  • 38. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
    Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
    [Abstract] [Full Text] [Related]

  • 39. Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
    Newman CB, Frisch KA, Rosenzweig B, Roubenoff R, Rey M, Kidder T, Kong Y, Pursnani A, Sedlis SP, Schwartzbard A, Kleinberg DL.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):122-32. PubMed ID: 20926529
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.